The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 40496/0033.
Aripiprazole 1mg/ml Oral Solution
Aripiprazole 1mg/ml Oral Solution
1. What Aripiprazole is and what it is used for
2. What you need to know before you take Aripiprazole
3. How to take Aripiprazole
4. Possible side effects
5. How to store Aripiprazole
6. Contents of the pack and other information.
Aripiprazole contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
Aripiprazole is used to treat:
Talk to your doctor or pharmacist before taking Aripiprazole if you suffer from:
Please tell your doctor if you notice you are gaining weight, develop unusual movements, experience somnolence that interferes with normal daily activities, any difficulty in swallowing or allergic symptoms.
Tell your doctor immediately if you are having any thoughts or feelings about hurting yourself. Suicidal thoughts and behaviours have been reported during aripiprazole treatment.
If you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat, please tell your doctor immediately.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/ relative should tell your doctor if you have ever had a stroke or “mini” stroke.
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings.
Your doctor may need to adjust or stop your dose.
Aripiprazole may cause sleepiness, fall in blood pressure when standing up, dizziness and changes in your ability to move and balance, which may lead to falls. Caution should be taken, particularly if you are an elderly patient or have some debility.
Please do not use this solution for children and adolescents under 13 years. It is not known if it is safe and effective in these patients.
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Taking Aripiprazole with some medicines may need to change your dose of Aripiprazole or the other medicines.
Especially tell your doctor if you are taking any of the following types of medicines:
These medicines increase the risk of side effects or reduce the effect of Aripiprazole; if you get any unusual symptom taking any of these medicines together with Aripiprazole, you should see your doctor.
Blood pressure-lowering medicines: Aripiprazole may increase the effect of medicines used to lower the blood pressure. Be sure to tell your doctor if you take a medicine to keep your blood pressure under control.
Medicines that increase the level of serotonin are typically used in conditions including depression, generalised anxiety disorder, obsessive-compulsive disorder (OCD) and social phobia as well as migraine and pain:
These medicines increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with Aripiprazole, you should see your doctor.
This solution can be taken regardless of meals. However, this solution should not be diluted with other liquids or mixed with any food prior to administration.
You should not take alcohol while taking this medicine.
If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
The following symptoms may occur in newborn babies, of mothers that have used Aripiprazole in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these symptoms you may need to contact your doctor.
If you are taking Aripiprazole, your doctor will discuss with you whether you should breast-feed considering the benefit to you of your therapy and the benefit to your baby of breast-feeding. You should not do both. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Dizziness and vision problems may occur during treatment with this medicine (see section 4).
This should be considered in cases where full alertness is required, e.g., when driving a car or handling machines.
This medicines also contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216), which may cause allergic reactions (possibly delayed).
This medicine also contains 200 mg fructose in each ml. Fructose may damage teeth. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.
This medicine also contains 400mg of sucrose in each ml. This should be taken into account in patients with diabetes mellitus. Sucrose may be harmful to the teeth.
This medicine contains 100 mg propylene glycol (E 1520) in each ml which is equivalent to 1.43 mg/kg.
If you suffer from a liver or kidney disease, do not take this medicine unless recommended by your doctor. Your doctor may carry out extra checks while you are taking this medicine.
This medicine also contains less than 1 mmol sodium (23 mg) per daily maximum dose 30mg (30 ml), that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose for adults is 15 ml solution (corresponding to 15 mg aripiprazole) once a day.
However your doctor may prescribe a lower or higher dose to a maximum of 30 mg (i.e. 30 ml) once a day.
The recommended dose for adolescents is 10ml solution (corresponding to 10 mg aripiprazole) once a day. However your doctor may prescribe a lower or higher dose to a maximum of 30 ml (i.e. 30 mg) once a day.
The dose of Aripiprazole must be measured using the calibrated 30ml cup or a 2ml graduated oral syringe supplied in the carton.
If you have the impression that the effect of Aripiprazole is too strong or too weak, talk to your doctor or pharmacist.
Try to take the Aripiprazole at the same time each day. It does not matter whether you take it with or without food. However, you should not dilute with other liquids or mix with other food prior to taking this solution.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole without first consulting your doctor.
If you realise you have taken more Aripiprazole than your doctor has recommended (or if someone else has taken some of your Aripiprazole), contact your doctor right away. If you cannot reach your doctor, go to the nearest hospital and take the pack with you.
Patients who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or hospital immediately if you experience any of the above.
If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.
Do not stop your treatment just because you feel better. It is important that you carry on taking Aripiprazole for as long as your doctor has told you to. Ask your doctor or pharmacist if you have any further questions on the use of this product.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known:
Tell your doctor if you experience any of these behaviours; he/she will discuss ways of managing or reducing the symptoms.
In elderly patients with dementia, more fatal cases have been reported while taking aripiprazole. In addition, cases of stroke or “mini” stroke have been reported.
Adolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepiness, uncontrollable twitching or jerking movements, restlessness, and tiredness were very common (greater than 1 in 10 patients) and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle twitching, uncontrolled movements of the limbs, and feeling dizzy, especially when getting up from a lying or sitting position, were common (greater than 1 in 100 patients).
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the bottle and on the carton. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use after 6 months of first opening the bottle.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Aripiprazole is a clear, colourless to light yellow liquid.
This medicine is available in 150 ml amber colored bottle with a child resistant tamper-evident closure, 30 ml measuring cup (graduated at every 2.5 ml equivalent to 2.5 mg) and a 2 ml oral syringe (graduated at every 0.5 ml equivalent to 0.5 mg) with an adaptor packed in a carton.
Marketing Authorisation Holder
Name and address
Aripiprazole 1mg/ml Oral Solution; PL 40496/0033
This leaflet was last revised in April 2023.
To request a copy of this leaflet in Braille, large print or audio format then please contact the marketing authorisation holder at the address (or email) above.
V13 18-04-23 D0